Can chronic or post-infectious immune activation contribute to cognitive decline?

Cognitive decline in later life is often multifactorial. Chronic or post-infectious immune activation is a biologically plausible contributor, but neither inflammatory markers nor evidence of prior infection establishes a primary infectious cause in an individual.

Clinical evidence

• In longitudinal meta-analyses of nondemented older adults, elevated peripheral inflammation predicted later cognitive decline modestly (overall OR 1.14). IL-6 was the most consistent signal (OR 1.23 and 1.34 across two analyses), whereas CRP was not significantly associated with decline.
• Experimental human endotoxin exposure increased inflammatory cytokines and impaired long-term memory, supporting a directionally adverse effect of acute inflammatory signaling on cognition. It does not, however, demonstrate that post-infectious inflammation causes chronic decline.
• Persistent cognitive symptoms and inflammatory associations have been reported after COVID-19, but heterogeneity and observational designs limit causal attribution.

Mechanistic context

• Sustained immune activation can maintain cytokine signaling, including IL-6. Neuroinflammatory/glial markers and pericyte injury have also been associated with poorer blood–brain barrier integrity in human cohorts; age-related barrier impairment was partly mediated by pericyte injury and neuroinflammation. These data support a plausible pathway linking systemic inflammation to brain vulnerability, not proof of causal direction.

Attribution and clinical implications

• Prior infection, isolated serum microbial IgG, or nonspecific cognitive change cannot establish that infection is the primary cause. Serum IgG usually reflects prior exposure—not active infection, CNS involvement, or causality.
• When an infectious cognitive syndrome is plausible, stronger attribution requires a compatible clinical syndrome plus CNS-focused evidence: CSF testing (e.g., pathogen PCR or pathogen-specific CSF antibody), MRI, EEG, and exclusion of alternative infectious and noninfectious causes.

Bottom line

• Chronic/post-infectious inflammation can plausibly contribute to cognitive worsening—particularly through IL-6-associated pathways—but infection alone does not establish the primary cause of cognitive decline.